Почетна › Рак на бели дробови со не-мали клетки › Флорида › Miami
Клинички испитувања за Рак на бели дробови со не-мали клетки во Miami, FL
Една студија за Рак на бели дробови со не-мали клетки бара учесници на локација во или блиску до Miami. Отворете ја за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Се регрутираФаза 3
- Miami Cancer Institute at Baptist Health, Inc. ( Site 0214), Miami
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Се регрутираФаза 1
- Exelixis Clinical Site #47, Miami
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Се регрутираФаза 3
- Miami Cancer Institute, Miami
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Се регрутираФаза 3
- Sylvester Comprehensive Cancer Center Miami, Miami
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- University of Miami, Miami
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Sylvester Comprehensive Cancer Center, Miami
- Baptist Health Miami Cancer Institute, Miami
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Се регрутираФаза 3
- Local Institution - 0696, Miami
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Се регрутираФаза 1/2
- Miami Cancer Institute, Miami
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Се регрутираФаза 1
- Sylvester Comprehensive Cancer Center, Miami
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Се регрутираФаза 1/2
- Sylvester Comprehensive Cancer Center - Miami, Miami
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Се регрутираФаза 1
- Biogenix Molecular, LLC, Miami
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Се регрутираФаза 2/3
- Miami Veterans Affairs Healthcare System, Miami
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Се регрутираФаза 1
- University of Miami, Miami
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- University of Miami, Miami
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Се регрутираФаза 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Sylvester Comprehensive Cancer Center, Miami
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Се регрутираФаза 3
- Miami Cancer Institute at Baptist Health, Miami
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Се регрутираФаза 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Се регрутираФаза 2
- University of Miami, Miami
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Се регрутираФаза 1/2
- Sylvester Comprehensive Cancer Center, Miami
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Се регрутираФаза 2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Bioresearch Partner, Miami
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Се регрутираФаза 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
A Study of VET3-TGI in Patients With Solid Tumors
Се регрутираФаза 1
- University of Miami, Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Се регрутираФаза 2
- Baptist Alliance - McI, Miami
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Се регрутира
- Miami VA Healthcare System, Miami, FL, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, Miami
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Се регрутираНабљудувачка студија
- Baptist Health South Florida, Miami
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY121 студија
- Arlington, VA104 студии
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH57 студии
- Washington, DC55 студии
Други студии во Miami
- Рак на дојка42 студии
- Рак (сите типови)36 студии
- Рак на простата27 студии
- Дебелина27 студии
- Акутна миелоидна леукемија24 студии
- Метастатски карцином23 студии
- Прекумерна телесна тежина23 студии
- Карцином на јајниците23 студии
- Улцерозен колитис21 студија
- Множен миелом21 студија
- Алцхајмерова болест20 студии
- Рак на бели дробови20 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.